The Agency for Healthcare Research and Quality (AHRQ) is presenting a special webinar ("What Works for Depression? An Evidence-based Comparison of Treatment Options") on Monday, April 29, 1:00 - 2:00 p.m. EDT. This event is free for AHRQ's Effective Health Care Program National Partnership Network members and their colleagues. We encourage you to share this notice by forwarding this email and announcing the event on your social media networks.
Presenter Gerald Gartlehner, M.D., M.P.H., will summarize findings from an AHRQ-funded CER on the comparative benefits and harms of 13 commonly prescribed second-generation antidepressants for the treatment of depressive disorders in adults. The presentation will focus on the comparative benefits and harms of drugs during acute, maintenance, and continuation phases of major depressive disorder. It will also address the treatment of dysthymia, subsyndromal depression, and patients with depression and accompanying symptoms such as anxiety, pain, or melancholia
Registration and Logistics
To register and receive information to access this webinar, please click on the following link and select "Attend Event" no later than Monday, April 22 http://ahrqdepressioncer.eventbrite.com. Seats are limited so be sure to RSVP since attendance is first-come, first-served.
Questions for Dr. Gartlehner? Send them to karen.costa@ahrq.hhs.gov no later than Monday, April 22. Questions sent prior to the webinar will receive priority during the Question & Answer portion of the agenda.
